Listen Live

Current Weather

Loading advertisement…

US FDA approves Merck’s combination HIV treatment

April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the health regulator's website showed on Tuesday. The two-drug combination of doravirine and islatravir was approved to replace the current antiretroviral regimen for treating HIV-1... Read More.